Jyotsna Sahni, MD
Sleep Medicine · Tucson, AZNPI 1417160599
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 62.9% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2024 at $16,302 and has fallen 70.2% since, to $4,863 in 2025.
Across 411 payments — averaging $91.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$24K
- Inspire Medical Systems, Inc.$4K
- ZOLL Respicardia, Inc.$2K
- Idorsia Pharmaceuticals US Inc$2K
- Harmony Biosciences LLC$1K
- Avadel CNS Pharmaceuticals, LLC$727
- plus $3K from 21 others
What the payments were for
- Consulting fees$1,6524%
- Speaking & faculty fees$17,65847%
- Travel & lodging$2,9348%
- Food & beverage$14,79439%
- Education$4751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 128 | $23,605 |
| Inspire Medical Systems, Inc. | 72 | $4,044 |
| ZOLL Respicardia, Inc. | 6 | $2,317 |
| Idorsia Pharmaceuticals US Inc | 25 | $1,999 |
| Harmony Biosciences LLC | 49 | $1,463 |
| Avadel CNS Pharmaceuticals, LLC | 21 | $727 |
| UCB, Inc. | 40 | $583 |
| Eisai Inc. | 13 | $379 |
| Itamar Medical Inc | 4 | $364 |
| Axsome Therapeutics, Inc. | 11 | $331 |
| Teva Pharmaceuticals USA, Inc. | 2 | $220 |
| Vanda Pharmaceuticals Inc. | 9 | $205 |
| Silk Road Medical, Inc. | 1 | $170 |
| Medtronic | 1 | $159 |
| Arbor Pharmaceuticals, Inc. | 8 | $151 |
| Biosense Webster, Inc. | 1 | $147 |
| Lilly USA, LLC | 2 | $139 |
| Merck | 6 | $130 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $111 |
| Boston Scientific | 1 | $95 |
| Philips North America LLC | 3 | $67 |
| Noctrix Health, Inc. | 1 | $26 |
| Almatica Pharma LLC | 1 | $18 |
| Fisher & Paykel Healthcare Inc | 1 | $18 |
| Aerin Medical Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Aytu Biopharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$20,471
- remede System$2,317
- Inspire$1,770
- QUVIVIQ$1,730
- Inspire Upper Airway Stimulation System$1,127
- WatchPATONE$297
- ENROUTE Transcarotid Stent$170
- ENROUTE Transcarotid Neuroprotection System$170
- NA$159
- Carto 3$147
- LUMRYZ$125
- Wakix$125
- SUNOSI$122
- KISUNLA$122
- AJOVY$116
- Dayvigo$107
- LifeVest$105
- AUSTEDO$104
How this compares
$37,513 in reported general payments places this provider in the 85th percentile of 47 sleep medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XyremSodium Oxybate | 12 | $219,922 |
| BelsomraSuvorexant | 20 | $13,445 |
| Zolpidem Tartrate | 84 | $3,098 |
| Gabapentin | 60 | $840 |
| Zaleplon | 52 | $834 |
| Ropinirole Hcl | 51 | $688 |
| Eszopiclone | 53 | $680 |
| Quetiapine Fumarate | 15 | $670 |
| Methadone Hcl | 44 | $644 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 28 | $322 |
| Clonazepam | 39 | $311 |
| Trazodone Hcl | 26 | $189 |
| Zolpidem Tartrate ErZolpidem Tartrate | 15 | $115 |
| Lorazepam | 20 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra | $130 | $13,44520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 47 sleep medicine providers in Arizona.
Other sleep medicine in Tucson
- Sairam ParthasarathyTucson$48K
- Aynur OkcayTucson$14K
- Salma PatelTucson$4K
- Daniel CombsTucson$969
- Erick LopezTucson$770
- Mark MecikalskiTucson$226
- Ruchir PatelScottsdale$374K
- Joyce Lee-IannottiPhoenix$126K
- Chad RuoffScottsdale$55K
- Jose de OcampoScottsdale$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.